Q-Line Biotech IPO is to open on May 21, 2026. It is an NSE SME IPOĀ that will raise ā¹214 crores. The Q-Line Biotech IPOĀ price band is fixed at ā¹326 to ā¹343 with a market lot of 11 Shares.
Q-Line Biotech IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 18 May | ā¹65 | – | 18.95% |
Q-Line Biotech IPO Details
Q-Line Biotech IPO Dates
| IPO Open Date: | May 21, 2026 |
| IPO Close Date: | May 25, 2026 |
| Basis of Allotment: | May 26, 2026 |
| Refunds: | May 27, 2026 |
| Credit to Demat Account: | May 27, 2026 |
| IPO Listing Date: | May 29, 2026 |
| IPO Bidding Cut-off Time: | May 25, 2026 – 5 PM |
Business Overview
Since its incorporation in 2013, Q-Line Biotech has been involved in the healthcare and diagnostic industry. The firm is known for manufacturing and supplying In-Vitro Diagnostic (IVD) products, medical diagnostic equipment, reagents, rapid test kits, and pathology instruments. The firm has been known to offer high-quality products and services at an affordable price range.
Q-Line Biotech has over 15 years of experience in the diagnostic industry and has served 150+ national and international clients. Moreover, the company also has 12 years of experience in developing and manufacturing various products. Its product range includes haematology, POC testing, clinical chemistry, molecular diagnostics, rapid tests, ELISA, and special diagnostics.
Q-Line Biotech IPO GMP aka Grey Market Premium FAQs:
What is Q-Line Biotech IPO GMP Today?
What is Q-Line Biotech IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Q-Line Biotech IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.



